查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1768228

全球心臟安全服務市場

Cardiac Safety Services
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 274 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球心臟安全服務市場規模將達 16 億美元

全球心臟安全服務市場規模預計在2024年達到8.859億美元，預計在2024-2030年的分析期間內將以10.0%的複合年成長率成長，到2030年將達到16億美元。心電圖/動態心電圖（ECG/Holter）測量是本報告分析的細分市場之一，預計其複合年成長率將達到10.0%，到分析期結束時規模將達到4.755億美元。血壓測量細分市場在分析期間內的複合年成長率預計為10.8%。

美國市場規模估計為 2.284 億美元，中國市場預計複合年成長率為 13.4%

美國心臟安全服務市場規模預計2024年達到2.284億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到3.618億美元，在2024-2030年的分析期內，複合年成長率將達到13.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為6.3%和7.9%。在歐洲，預計德國市場的複合年成長率約為7.4%。

全球心臟安全服務市場－主要趨勢與促進因素摘要

為什麼心臟安全服務在臨床試驗中很重要？

心臟安全服務在臨床試驗中至關重要，尤其是在涉及新藥的臨床試驗中，以確保受試藥物不會對心臟產生不良影響。這些服務監測和評估潛在的心臟風險，例如心律不整、QT間期延長以及藥物治療可能引起的其他心血管副作用。由於美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等監管機構對臨床試驗期間的心臟安全性評估制定了嚴格的指導方針，因此公司必須遵守全面的心臟安全通訊協定，以確保新藥對患者的安全。

心臟安全服務涵蓋一系列診斷評估，例如心電圖 (ECG)、連續型心電圖監測)、血壓監測和超音波心臟檢查。這些評估可檢測心臟毒性的早期徵兆，並有助於指導繼續、修改或終止藥物開發的決策。隨著患者安全和長期心血管健康結果在藥物開發過程中變得越來越重要，心臟安全服務已變得至關重要，以確保藥物不僅在短期使用中是安全的，而且在老年人和患有潛在心臟病等弱勢群體的長期使用中也是安全的。

科技進步如何影響心臟安全服務市場？

技術進步正在顯著提高臨床試驗中心臟安全服務的準確性、效率和容量。最顯著的進步之一是利用數位技術和穿戴式裝置進行持續心臟監測。可攜式心電圖監測儀和穿戴式心臟監測儀等設備可以長時間即時追蹤心臟活動，從而更全面地了解臨床實驗中患者的心臟健康狀況。這些技術不僅提供高解析度數據，還支援遠端監測，從而實現更靈活的試驗設計，並減少患者頻繁訪問臨床機構的需求。

此外，人工智慧 (AI) 和機器學習 (ML) 的進步正在徹底改變心臟安全資料的分析方式。人工智慧主導的平台可以快速處理大量心臟數據，並識別人類分析師可能無法立即察覺的細微模式和異常。這些技術也提高了心臟評估的預測能力，能夠更早發現潛在風險，並增強整個藥物開發過程中的決策能力。此外，雲端基礎的解決方案正在促進臨床試驗機構和申辦者之間心臟安全資料的安全共用，從而改善協作並加快監管提交流程。這些技術創新正在提高心臟安全服務的可靠性和可近性，幫助製藥公司簡化臨床試驗流程。

哪些產業趨勢推動了對心臟安全服務的需求？

產業趨勢推動了心臟安全服務需求的成長，尤其是臨床試驗日益複雜，以及法規環境對心血管安全的日益重視。隨著製藥公司開發針對癌症、自體免疫疾病和代謝紊亂等疾病的更複雜治療方法，許多此類藥物都存在很高的心血管副作用風險。對於生物製藥、免疫療法和基因療法尤其如此，在這些療法中，心臟監測對於確保患者安全至關重要。此類治療的高風險，加上嚴格的監管審查，促使公司大力投資全面的心臟安全服務，以降低其臨床項目的風險。

另一個關鍵趨勢是精準醫療和以病人為中心的臨床試驗日益受到重視。隨著藥物開發商根據特定基因譜和亞群客製化治療方法，個人化治療相關的心臟安全風險可能存在顯著差異。這需要更有針對性的心臟監測和安全評估。此外，老年人口中慢性病（尤其是心血管疾病）的盛行率不斷上升，推動了臨床試驗中對更廣泛的心臟安全評估的需求，因為已有疾病的患者通常會參與藥物試驗。分散式和混合式臨床試驗的興起（患者可以在家中參與）也推動了對先進的遠端心臟監測解決方案的需求。

心臟安全服務市場成長受多種因素推動

心臟安全服務市場的成長受到多種因素的推動，包括臨床試驗日益複雜、監測技術的進步以及心血管安全評估監管要求的不斷提高。隨著製藥業開發更具針對性且風險更高的治療方法，心臟安全監測已成為藥物開發過程中確保患者安全的重要組成部分。臨床試驗族群中心血管疾病和其他慢性疾病的盛行率不斷上升，進一步凸顯了製定嚴格的心臟安全通訊協定的必要性。

人工智慧分析、穿戴式心電圖設備和雲端基礎平台等技術進步也推動了市場成長，提高了心臟安全評估的準確性、可及性和效率。這些創新對於依賴遠端監控技術從傳統臨床試驗地點以外的參與患者收集即時心臟數據的分散式臨床試驗尤其重要。此外，個人化醫療日益受到關注，也推動了針對需要專門監控和數據分析的特定患者亞群客製化心臟安全解決方案的需求。

市場成長的另一個關鍵驅動力是全球臨床試驗的擴張，尤其是在新興市場。隨著製藥公司將臨床研究活動拓展到新的地區，他們需要符合當地監管標準並維持高準確性和一致性的在地化心臟安全服務。這一趨勢也受到監管要求日益複雜的推動，因為世界各地的衛生當局在醫藥品認證過程中要求提供更嚴格的心血管安全數據。這些因素，加上先進技術的日益普及，預計將推動心臟安全服務市場的持續成長。

部分

服務類型（心電圖/動態心電圖監測、血壓監測、心血管影像、全面 QT 研究、其他服務類型）；最終用戶（製藥/生物製藥公司、合約研究組織）

受訪公司範例

  • Banook Group
  • Bioclinica（A Subsidiary of Cinven）
  • BioTelemetry, Inc.
  • Biotrial
  • Celerion, Inc.
  • Certara, LP
  • ERT, Inc.
  • IQVIA
  • Labcorp
  • Medpace
  • Ncardia
  • Pharmaceutical Product Development LLC
  • PhysioStim
  • Richmond Pharmacology
  • SGS SA
  • Shanghai Medicilon Inc.

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP21437

Global Cardiac Safety Services Market to Reach US$1.6 Billion by 2030

The global market for Cardiac Safety Services estimated at US$885.9 Million in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. ECG / Holter Measurement, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$475.5 Million by the end of the analysis period. Growth in the Blood Pressure Measurement segment is estimated at 10.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$228.4 Million While China is Forecast to Grow at 13.4% CAGR

The Cardiac Safety Services market in the U.S. is estimated at US$228.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$361.8 Million by the year 2030 trailing a CAGR of 13.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.3% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.

Global Cardiac Safety Services Market - Key Trends & Drivers Summarized

Why Are Cardiac Safety Services Critical in Clinical Trials?

Cardiac safety services are essential in clinical trials, particularly those involving new pharmaceuticals, as they ensure that the drugs being tested do not have adverse effects on the heart. These services monitor and assess potential cardiac risks such as arrhythmias, QT prolongation, and other cardiovascular side effects that could arise from drug therapies. With regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) placing stringent guidelines on cardiac safety assessments during clinical trials, companies must comply with comprehensive cardiac safety protocols to ensure that new drugs are safe for patients.

Cardiac safety services include a range of diagnostic evaluations such as electrocardiograms (ECGs), Holter monitoring, blood pressure monitoring, and echocardiography. These assessments help detect early signs of cardiotoxicity and guide decisions on the continuation, modification, or cessation of a drug’s development. As drug development processes become increasingly focused on patient safety and long-term cardiovascular health outcomes, cardiac safety services are becoming indispensable in ensuring that therapies are safe not only for short-term use but also for chronic administration in vulnerable populations, including the elderly and those with pre-existing heart conditions.

How Are Technological Advancements Shaping the Cardiac Safety Services Market?

Technological advancements are significantly enhancing the accuracy, efficiency, and capabilities of cardiac safety services in clinical trials. One of the most notable advancements is the use of digital technologies and wearables for continuous cardiac monitoring. Devices like portable ECG monitors and wearable heart monitors allow for real-time tracking of cardiac activity over extended periods, offering a more comprehensive view of a patient’s heart health during drug trials. These technologies not only provide high-resolution data but also allow for remote monitoring, enabling more flexible trial designs and reducing the need for patients to visit clinical sites frequently.

Moreover, advancements in artificial intelligence (AI) and machine learning (ML) are revolutionizing the way cardiac safety data is analyzed. AI-driven platforms can rapidly process large volumes of cardiac data, identifying subtle patterns and abnormalities that may not be immediately apparent to human analysts. These technologies are also improving the predictive capabilities of cardiac assessments, enabling earlier detection of potential risks and enhancing decision-making throughout the drug development process. Additionally, cloud-based solutions are facilitating the secure sharing of cardiac safety data between trial sites and sponsors, improving collaboration and speeding up the regulatory submission process. These innovations are increasing the reliability and accessibility of cardiac safety services, helping pharmaceutical companies streamline their clinical trials.

What Industry Trends Are Driving the Demand for Cardiac Safety Services?

Several industry trends are driving the rising demand for cardiac safety services, particularly the increasing complexity of clinical trials and the regulatory environment’s growing emphasis on cardiovascular safety. As pharmaceutical companies develop more sophisticated therapies targeting conditions like cancer, autoimmune diseases, and metabolic disorders, many of these drugs come with a higher potential for cardiovascular side effects. This is especially true for biologics, immunotherapies, and gene therapies, where cardiac monitoring becomes critical in ensuring patient safety. The high stakes associated with these therapies, combined with stringent regulatory oversight, are pushing companies to invest heavily in comprehensive cardiac safety services to de-risk their clinical programs.

Another important trend is the growing focus on precision medicine and patient-centric trials. As drug developers tailor therapies to specific genetic profiles and subpopulations, the cardiac safety risks associated with personalized treatments can vary significantly. This necessitates more targeted cardiac monitoring and safety assessments. Additionally, the increasing incidence of chronic diseases, particularly cardiovascular diseases, among aging populations is driving demand for more extensive cardiac safety evaluations in clinical trials, as patients with pre-existing conditions often participate in drug studies. The rise of decentralized and hybrid clinical trials, in which patients can participate from home, is also boosting the need for advanced remote cardiac monitoring solutions.

Growth in the Cardiac Safety Services Market Is Driven by Several Factors

Growth in the cardiac safety services market is driven by several factors, including the rising complexity of clinical trials, advancements in monitoring technologies, and increasing regulatory requirements for cardiovascular safety assessments. As the pharmaceutical industry develops more targeted and high-risk therapies, cardiac safety monitoring has become an integral part of the drug development process to ensure patient safety. The rising incidence of cardiovascular diseases and other chronic conditions in clinical trial populations further emphasizes the need for stringent cardiac safety protocols.

Technological advancements, such as AI-powered analytics, wearable ECG devices, and cloud-based platforms, are also propelling market growth by improving the accuracy, accessibility, and efficiency of cardiac safety assessments. These innovations are particularly important in decentralized clinical trials, which rely on remote monitoring technologies to collect real-time cardiac data from patients participating outside of traditional trial sites. Moreover, the increasing focus on personalized medicine is driving demand for customized cardiac safety solutions tailored to specific patient subgroups, requiring specialized monitoring and data analysis.

Another key driver of market growth is the expansion of global clinical trials, particularly in emerging markets. As pharmaceutical companies broaden their clinical research activities to new regions, they require localized cardiac safety services that comply with regional regulatory standards while maintaining high levels of precision and consistency. This trend is further supported by the increasing complexity of regulatory requirements, as health authorities worldwide demand more rigorous cardiovascular safety data during the drug approval process. These factors, combined with the growing adoption of advanced technologies, are expected to drive the sustained growth of the cardiac safety services market.

SCOPE OF STUDY:

The report analyzes the Cardiac Safety Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies, Other Service Types); End-Use (Pharma & Biopharma Companies, Contract Research Organizations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Banook Group
  • Bioclinica (A Subsidiary of Cinven)
  • BioTelemetry, Inc.
  • Biotrial
  • Celerion, Inc.
  • Certara, L.P.
  • ERT, Inc.
  • IQVIA
  • Labcorp
  • Medpace
  • Ncardia
  • Pharmaceutical Product Development LLC
  • PhysioStim
  • Richmond Pharmacology
  • SGS S.A.
  • Shanghai Medicilon Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Cardiac Safety Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases and Drug-Induced Cardiotoxicity Drives Demand for Cardiac Safety Assessment Services
    • Increasing Emphasis on Patient Safety and Regulatory Compliance Strengthens Market Demand for Cardiac Safety Monitoring in Clinical Trials
    • Growth in Drug Development and Clinical Research Activities Expands Addressable Market for Cardiac Safety Services
    • Technological Advancements in Cardiac Imaging and Biomarkers Propel Adoption of Advanced Cardiac Safety Assessment Methods
    • Rising Demand for Comprehensive ECG and QT Interval Monitoring in Clinical Trials Boosts Cardiac Safety Service Market
    • Growing Focus on Early Detection of Cardiotoxicity in Oncology and Immunotherapy Creates New Growth Opportunities in Cardiac Safety Services
    • Expansion of Contract Research Organizations (CROs) and Outsourcing of Cardiac Safety to Specialized Providers Fuels Market Growth
    • Increasing Use of Wearable and Remote Monitoring Devices in Clinical Trials Enhances Real-Time Cardiac Safety Data Collection
    • Growing Integration of AI and Machine Learning in Cardiac Safety Analytics Improves Predictive Capabilities and Efficiency
    • Rising Adoption of Electrocardiographic Monitoring in Early-Phase Clinical Trials Strengthens Market for Cardiac Safety Services
    • Increasing Demand for Non-Invasive Cardiac Monitoring Methods Expands Scope of Cardiac Safety Services in Diverse Patient Populations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Cardiac Safety Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cardiac Safety Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for ECG / Holter Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for ECG / Holter Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for ECG / Holter Measurement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Blood Pressure Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Blood Pressure Measurement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Blood Pressure Measurement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cardiovascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cardiovascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cardiovascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Thorough QT Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Thorough QT Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Thorough QT Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • CHINA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cardiac Safety Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cardiac Safety Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • INDIA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Cardiac Safety Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Cardiac Safety Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Cardiac Safety Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Cardiac Safety Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Cardiac Safety Services by End-Use - Pharma & Biopharma Companies and Contract Research Organizations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Cardiac Safety Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies and Contract Research Organizations for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Cardiac Safety Services by Service Type - ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Cardiac Safety Services by Service Type - Percentage Breakdown of Value Sales for ECG / Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies and Other Service Types for the Years 2015, 2025 & 2030

IV. COMPETITION